Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach
Carcinogenesis and Chemotherapy · 2023
DOI: 10.31579/2835-9216/011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis and Chemotherapy, 2023. Verfasst von Iffat Jamal.
Abstract (Originalsprache)
Pediatric chronic myeloid leukaemia (CML) is relatively uncommon. Lacking strong clinical study evidence, therapy of CML in children is not standardised and frequently adheres to recommendations made for adults. The clinical presentation of adolescents and young adults is typically more aggressive than that of older individuals, and prognostic ratings for adult CML do not apply to children.
Zitieren
APA
Jamal, I. (2023). Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach. Carcinogenesis and Chemotherapy. https://doi.org/10.31579/2835-9216/011
Vancouver
Jamal I. Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach. Carcinogenesis and Chemotherapy. 2023. doi:10.31579/2835-9216/011
BibTeX
@article{Jamal2023,
author = {Jamal, Iffat},
title = {Pediatric Chronic Myeloid Leukemia: A Rare and Unique Disease Requiring Different Diagnostic and Therapeutic Approach},
journal = {Carcinogenesis and Chemotherapy},
year = {2023},
doi = {10.31579/2835-9216/011}
}
EUVIMED